ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 5176

$1.12M Total Retail Price of All Prescriptions

Rank: 197 out of 5176

556 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 16,621 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 1,062 895 1 1
OMEPRAZOLE 739 610 2 3
LISINOPRIL 704 584 3 5
ZOLPIDEM TARTRATE 670 563 4 17
METFORMIN HCL 593 455 5 7
AMLODIPINE BESYLATE 576 503 6 2
LEVOTHYROXINE SODIUM 461 387 7 4
HYDROCHLOROTHIAZIDE 448 375 8 10
TRAMADOL HCL 448 360 8 40
MELOXICAM 339 303 10 53
ATENOLOL 336 326 11 12
LOSARTAN POTASSIUM 335 299 12 14
NEXIUM 304 276 13 16
ALENDRONATE SODIUM 301 288 14 18
METOPROLOL TARTRATE 294 249 15 6
GABAPENTIN 255 215 16 21
CLOTRIMAZOLE-BETAMETHASONE 251 221 17 94
LOVAZA 232 200 18 43
AZITHROMYCIN 217 169 19 42
MECLIZINE HCL 210 198 20 81
CIPROFLOXACIN HCL 201 163 21 84
SINGULAIR 191 139 22 62
SYMBICORT 182 131 23 120
CRESTOR 172 156 24 15
FUROSEMIDE 171 141 25 8
TRIAMCINOLONE ACETONIDE 170 123 26 125
FLUTICASONE PROPIONATE 168 128 27 38
PROAIR HFA 161 99 28 60
NIFEDIPINE ER 160 157 29 48
JANUVIA 159 132 30 25
MEGESTROL ACETATE 158 153 R 31 263
AMMONIUM LACTATE 148 131 32 91
CILOSTAZOL 144 136 33 206
FENOFIBRATE 136 100 34 102
ENALAPRIL MALEATE 133 123 35 22
LOSARTAN-HYDROCHLOROTHIAZIDE 133 104 35 35
DONEPEZIL HCL 131 127 37 28
SERTRALINE HCL 124 101 38 30
LEVOCETIRIZINE DIHYDROCHLORIDE 123 93 39 364
PLAVIX 123 112 39 29
CLOPIDOGREL 120 101 41 26
METOPROLOL SUCCINATE 118 114 42 11
DIOVAN HCT 117 113 43 39
VENTOLIN HFA 107 59 44 64
SYNTHROID 106 56 45 33
MONTELUKAST SODIUM 106 87 45 123
GLIMEPIRIDE 104 77 47 37
ONGLYZA 104 103 47 153
LANSOPRAZOLE 100 79 49 113
PATANOL 99 75 50 158
ADVAIR DISKUS 97 81 51 32
GLYBURIDE 95 71 R 52 67
ATORVASTATIN CALCIUM 91 91 53 9
ALLOPURINOL 89 63 54 41
TAMSULOSIN HCL 87 87 55 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 58 56 49
NAPROXEN 82 70 57 95
COLCRYS 79 65 58 170
ACTOS 76 72 59 85
PROCTOZONE-HC 75 47 60 171
ISOSORBIDE MONONITRATE ER 74 64 61 44
NASONEX 74 65 61 178
GLIPIZIDE 74 70 61 63
RANITIDINE HCL 73 61 64 36
SOLARAZE 72 66 65 157
FOSINOPRIL SODIUM 72 58 65 105
DILTIAZEM 24HR CD 71 67 67 119
CELEBREX 71 68 67 80
BYSTOLIC 70 51 69 96
NAMENDA 70 70 69 47
ACTONEL 68 46 71 134
WARFARIN SODIUM 68 64 71 13
IBANDRONATE SODIUM 65 45 73 211
PREDNISONE 64 50 74 52
SINGLE USE SWAB 64 61 74 108
AMOX TR-POTASSIUM CLAVULANATE 64 51 74 141
TRILIPIX 63 47 77 187
POTASSIUM CHLORIDE 62 57 78 34
AZOR 60 51 79 194
DIOVAN 59 37 80 19
LYRICA 58 49 81 133
SPIRIVA 56 56 82 54
NIZATIDINE 56 40 82 430
MUPIROCIN 56 39 82 182
OXYBUTYNIN CHLORIDE ER 56 49 82 204
HYDROCODONE-ACETAMINOPHEN 55 49 S3 86 27
VOLTAREN 55 49 86 97
AVODART 54 54 88 107
GLIPIZIDE XL 52 52 89 83
IBUPROFEN 52 29 89 72
NYSTATIN-TRIAMCINOLONE 52 41 89 142
FLECTOR 51 40 92 282
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.